Skip to content

Clinical trials

Kidney Calculi trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Calculi Country / region: China Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20153
20164
20173
20181
20191
20202
20214
20225
20233
20244
202512
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16
Completed15
Recruiting8
Not yet recruiting4
Enrolling by invitation2
Withdrawn1
Terminated1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Affiliated Hospital of Guangzhou Medical University20
Changhai Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2
The First Affiliated Hospital of University of South China2
Chinese Medical Association1
First Affiliated Hospital of Guangxi Medical University1
Gao Xiaofeng1
Guohua Zeng1
Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Calculi48
Nephrolithiasis8
Urolithiasis4
Ureterolithiasis3
Recurrence2
Sepsis2
Urinary Bladder Neoplasms2
Urinary Tract Infections2
Adrenal Gland Neoplasms1
Autoimmune Diseases1

Trials

Showing 76 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.